Pure Global

Effect of Metabolic Dysfunction in Branched-chain Amino Acids on Cardiac Function in Patients With Sepsis - Trial NCT06258252

Access comprehensive clinical trial information for NCT06258252 through Pure Global AI's free database. This phase not specified trial is sponsored by West China Hospital and is currently Not yet recruiting. The study focuses on Sepsis. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06258252
Not yet recruiting
other
Trial Details
ClinicalTrials.gov • NCT06258252
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Metabolic Dysfunction in Branched-chain Amino Acids on Cardiac Function in Patients With Sepsis
Effect of Metabolic Dysfunction in Branched-chain Amino Acids on Cardiac Function in Patients With Sepsis: an Observational Study

Study Focus

Sepsis

Effect of BCAAs metabolic dysfunction on cardiac function in sepsis

Observational

other

Sponsor & Location

West China Hospital

Timeline & Enrollment

N/A

Mar 15, 2024

Mar 15, 2026

50 participants

Primary Outcome

The incidence of Sepsis induced cardiomyopathy

Summary

The current project was designed to examine the effects of BCAA metabolic dysfunction on
 cardiac function in septic patients.

ICD-10 Classifications

Other sepsis
Sepsis, unspecified
Other specified sepsis
Candidal sepsis
Puerperal sepsis

Data Source

ClinicalTrials.gov

NCT06258252

Non-Device Trial